In addition, by specifically analysing various immune checkpoints (Supplementary Fig. 8), we identified a significant upregulation of the immunosuppressive CD200 molecule (Fig. 5d), which might serve as a potential immunotherapeutic target in chemo-treated cervical cancer. Here, CD200 is linked to cervical carcinoma.